Is Ticagrelor the Antiplatelet Therapy Panacea?

by Beitelshees, Amber L.
Published 2010

Renin–angiotensin–aldosterone system (RAAS) pharmacogenomics: implications in heart failure management

by Beitelshees, Amber L., Zineh, Issam
Published in Heart Fail Rev (2008)

Evolving research and stakeholder perspectives on pharmacogenomics

by Beitelshees, Amber L., Veenstra, David L.
Published 2011

Personalized antiplatelet and anticoagulation therapy: applications and significance of pharmacogenomics

by Beitelshees, Amber L, Voora, Deepak, Lewis, Joshua P
Published in Pharmgenomics Pers Med (2015)

Sodium–Glucose Cotransporter 2 Inhibitors: A Case Study in Translational Research

by Beitelshees, Amber L., Leslie, Bruce R., Taylor, Simeon I.
Published in Diabetes (2019)

Pharmacological treatment of hyperglycemia in type 2 diabetes

by Taylor, Simeon I., Yazdi, Zhinous Shahidzadeh, Beitelshees, Amber L.
Published in J Clin Invest (2021)

Cost-Effectiveness of Cytochrome P450 2C19 Genotype Screening for Selection of Antiplatelet Therapy with Clopidogrel or Prasugrel

by Reese, Emily S., Mullins, C. Daniel, Beitelshees, Amber L., Onukwugha, Eberechukwu
Published 2012

Serum Monocyte Chemoattractant Protein-1 Concentrations Associate With Diabetes Status but Not Arterial Stiffness in Children With Type 1 Diabetes

by Zineh, Issam, Beitelshees, Amber L., Silverstein, Janet H., Haller, Michael J.
Published 2009

SGLT2 Inhibitors as Adjunctive Therapy for Type 1 Diabetes: Balancing Benefits versus Risks

by Taylor, Simeon I., Blau, Jenny E., Rother, Kristina I., Beitelshees, Amber L.
Published in Lancet Diabetes Endocrinol (2019)

Single nucleotide polymorphism discovery and haplotype analysis of Ca(2+)-dependent K(+) channel beta-1 subunit

by Gong, Yan, Beitelshees, Amber L., Wessel, Jennifer, Langaee, Taimour Y., Schork, Nicholas J., Johnson, Julie A.
Published 2007

CXCL5 polymorphisms are associated with variable blood pressure in cardiovascular disease-free adults

by Beitelshees, Amber L, Aquilante, Christina L, Allayee, Hooman, Langaee, Taimour Y, Welder, Gregory J, Schofield, Richard S, Zineh, Issam
Published 2012

Using Workflow Modeling to Identify Areas to Improve Genetic Test Processes in the University of Maryland Translational Pharmacogenomics Project

by Cutting, Elizabeth M., Overby, Casey L., Banchero, Meghan, Pollin, Toni, Kelemen, Mark, Shuldiner, Alan R., Beitelshees, Amber L.
Published in AMIA Annu Symp Proc (2015)

Epithelial Neutrophil-Activating Peptide (ENA-78), Acute Coronary Syndrome Prognosis, and Modulatory Effect of Statins

by Zineh, Issam, Beitelshees, Amber L., Welder, Gregory J., Hou, Wei, Chegini, Nasser, Wu, Jun, Cresci, Sharon, Province, Michael A., Spertus, John A.
Published 2008

Comparison of Office, Ambulatory, and Home Blood Pressure Antihypertensive Response to Atenolol and Hydrochlorthiazide

by Beitelshees, Amber L., Gong, Yan, Bailey, Kent R., Turner, Stephen T., Chapman, Arlene B., Schwartz, Gary L., Gums, John G., Boerwinkle, Eric, Johnson, Julie A.
Published 2009

Adrenergic-pathway Gene Variants Influence β-Blocker-related Outcomes after Acute Coronary Syndrome in a Race-specific Manner

by Cresci, Sharon, Dorn, Gerald W., Jones, Philip G., Beitelshees, Amber L., Li, Allie Y., Lenzini, Petra A., Province, Michael A., Spertus, John A., Lanfear, David E.
Published 2012

A PPARα Promoter Variant Impairs ERR-Dependent Transactivation and Decreases Mortality after Acute Coronary Ischemia in Patients with Diabetes

by Cresci, Sharon, Huss, Janice M., Beitelshees, Amber L., Jones, Philip G., Minton, Matt R., Dorn, Gerald W., Kelly, Daniel P., Spertus, John A., McLeod, Howard L.
Published 2010

Plasma Renin Activity Predicts Blood Pressure Responses to β-Blocker and Thiazide Diuretic as Monotherapy and Add-On Therapy for Hypertension

by Turner, Stephen T., Schwartz, Gary L., Chapman, Arlene B., Beitelshees, Amber L., Gums, John G., Cooper-DeHoff, Rhonda M., Boerwinkle, Eric, Johnson, Julie A., Bailey, Kent R.
Published 2010

Power to identify a genetic predictor of antihypertensive drug response using different methods to measure blood pressure response

by Turner, Stephen T, Schwartz, Gary L, Chapman, Arlene B, Beitelshees, Amber L, Gums, John G, Cooper-DeHoff, Rhonda M, Boerwinkle, Eric, Johnson, Julie A, Bailey, Kent R
Published 2012

Transethnic meta-analysis suggests genetic variation in the HEME pathway influences potassium response in patients treated with hydrochlorothiazide

by Del-Aguila, Jorge L., Cooper-DeHoff, Rhonda M., Chapman, Arlene B., Gums, John G., Beitelshees, Amber L., Bailey, Kent, Turner, Stephen T., Johnson, Julie A., Boerwinkle, Eric
Published in Pharmacogenomics J (2014)

Blood Pressure Responses and Metabolic Effects of Hydrochlorothiazide and Atenolol

by Smith, Steven M., Gong, Yan, Turner, Stephen T., Cooper-DeHoff, Rhonda M., Beitelshees, Amber L., Chapman, Arlene B., Boerwinkle, Eric, Bailey, Kent, Johnson, Julie A., Gums, John G.
Published 2011